Personalized therapy of pediatric B-ALL (NMFZ)
Laufzeit: 01.01.2017 - 31.12.2018
imported
Kurzfassung
Personalized therapy of pediatric B-ALL: molecular determinants of CD19 splice variants as a biomarker for the resistance to CAR 19-therapy
